PET and SPECT in hepatic and uraemic encephalopathy

Georg Berding, Frank Bengel

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Liver or kidney failure can disturb brain function to a variable extent. If organ failure is treated successfully, brain function is normally at least in part restored. A broad spectrum of radiotracer imaging methods has been employed to measure correlates of brain function and thereby elucidate the pathophysiology of hepatic r uraemic encephalopathy. Measurements of regional cerebral perfusion as well as energy metabolism in hepatic encephalopathy (HE) mostly revealed reductions in areas (particularly the frontal cortex and cingulum) relevant for thetypically observed functional defi cits (e.g. in attention or movement initiation). PET studies demonstrated that in HE, brain uptake of the neurotoxic ammonia increases with its plasma concentration. Some studies using the biomarker C-11-PK11195 indicate the presence of neuroinfl ammation in HE. Different neuroreceptor systems have been studied in HE throughout demonstrating reduced binding – particularly to central GABA-A receptors and dopamine as well as serotonin transporters. In patients with chronic renal failure and particularly those with depressive mood, reductions of cerebral blood fl ow and energy metabolism have been demonstrated, primarily located in the frontal cortex.

Original languageEnglish (US)
Title of host publicationPet and Spect in Neurology
PublisherSpringer Berlin Heidelberg
Pages797-814
Number of pages18
ISBN (Electronic)9783642543074
ISBN (Print)9783642543067
DOIs
StatePublished - Jan 1 2014

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'PET and SPECT in hepatic and uraemic encephalopathy'. Together they form a unique fingerprint.

Cite this